logo-loader
NYSEMKT:VNRX

VolitionRx

Receive alerts
Market:
NYSEMKT
Market Cap:
$154.86 m
Price
3.35 USD
Change
3.72%
52 weeks high
6.83
52 weeks low
2.22

In brief

Volition is a multi-national life sciences company developing simple, easy to use blood-based cancer tests to accurately diagnose a range of cancers. The tests are based on the science of Nucleosomics®, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid -- an indication that disease is present.

 

Deep dive We explore the investor case for growth companies

Snapshot

Nu.Q test screens for colorectal and prostate cancers, and may have the potential to detect coronavirus (COVID-19) patients most at-risk for hospitalization or respiratory support

Insight Widest with the analysis, Proactive gives perspectives that others don't.

Small cap growth stocks in the spotlight at Proactive’s virtual event on July 21

Joining Proactive this time out are environmental engineering company BioLargo; life sciences group VolitionRx, and digital media platform Bright Mountain Media

2 weeks, 5 days ago